Get started
Author

Megan Wheelden

Observed name: M. Wheelden
ORCID: 0000-0002-0234-5550
Observed ORCID: 0000-0002-0234-5550
OpenAlex ID: A5058324278
A Novel Adverse Event Associated with Olaparib Therapy in a Patient with Metastatic Breast Cancer
2018 · Megan Wheelden, Leah Cream, et al. · Case Reports in Oncological Medicine · 11
PDF
Durable Major Response With Pazopanib in Recurrent, Heavily Pretreated Metastatic Esthesioneuroblastoma Harboring a Fumarate Hydratase Mutation
2021 · Marianne Spengler, Megan Wheelden, et al. · JCO Precision Oncology · 9
Clinical Evaluation of the Safety and Efficacy of Trifluridine/Tipiracil in the Treatment of Advanced Gastric/Gastroesophageal Junction Adenocarcinoma: Evidence to Date
2020 · Megan Wheelden, Nelson s Yee · OncoTargets and Therapy · 8
PDF
Dobbs v Jackson- Rewriting Women's Autonomy in Cancer Care
2023 · Kriti Mittal, Melanie Sheen, et al. · JCO Oncology Practice · 3
PDF
Retrospective Cohort Study Evaluating the Association Between Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use and Tyrosine Kinase Inhibitor-Associated Toxicity in Advanced Renal Cell Carcinoma
2026 · Theodore Joseph Miller, Junjia Zhu, et al. · Journal of Urologic Oncology
PDF
Angelica herbal supplement AGN-Cogni.Q acute dose safety and pharmacokinetics (PK) dose-response in prostate cancer patients.
2026 · Monika Joshi, Tongyao Fan, et al. · Journal of Clinical Oncology
Evaluation of the safety and efficacy of daily oral Angelica gigas Nakai (AGN)-INM176 in prostate cancer patients with rising plasma PSA (phase I/II trial).
2026 · Monika Joshi, Todd D. Schell, et al. · Journal of Clinical Oncology
Management options for node-positive muscle-invasive bladder cancer.
2024 · Hyma V Polimera, Priyanka Bhatia, et al. · PubMed
PSMA-PET Radiopharmaceutical Image Scoring Method (PRISM): A Practical Tool for Predicting 177lu-PSMA-617 Therapy Outcomes in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
2024 · H.V. Polimera, M. Tulchinsky, et al. · International Journal of Radiation Oncology*Biology*Physics
Retrospective study assessing the use of angiotensin converting enzyme inhibitors or angiotensin receptor blockers to reduce toxicity from tyrosine kinase inhibitors in metastatic renal cell carcinoma.
2024 · Theodore Joseph Miller, Ashok Maddukuri, et al. · Journal of Clinical Oncology
Utility of concurrent immunoradiation for locally advanced and/or medically inoperable melanoma and Merkel cell carcinoma.
2019 · Joyson Poulose, Megan Wheelden, et al. · Journal of Clinical Oncology
Small cell bladder carcinoma: Single institution experience.
2019 · Megan Wheelden, Matthew Kaag, et al. · Journal of Clinical Oncology
Persistent high levels of circulating effector memory T cells and anti-nuclear antibodies in metastatic melanoma patients who experience durable CRs to immunotherapy after the cessation of treatment.
2018 · Megan Wheelden, Jeremy Haley, et al. · Journal of Clinical Oncology
Works count: 13
Citation count: 31
H-index: 3
I10-index: 1
Year
Topic
Type